Travel Vaccines Market

Market Insights

The travel vaccines market is expected to reach US$ 6,886.7 million by 2026, up from US$ 3,592.1 million in 2017, with a compounded annual growth rate (CAGR) of 7.5% from 2018 to 2026. As per the research findings of the World Tourism Organization (WTO), the number of international arrivals throughout the globe is expected to reach 1.6 billion by 2020. It is estimated that 51% of these travelers traveled for holiday and recreational purposes, 15% traveled for business purposes, and 24% reported travel for religious reasons and pilgrimages.

Travelers are at high risk for bacterial and viral infection due to sudden changes in humidity, altitude, and temperature, poor hygiene, and a lack of medical services in remote areas, etc. The World Health Organization (WHO) has drafted a treatment guideline for travelers, primarily focusing on the importance of vaccination as a preventive measure classified as routine, recommended, and required vaccination.

Market Synopsis

Required vaccinations are gaining prominence due to the sudden outbreak of fatal diseases such as ebola, zika, and the Middle East respiratory syndrome.

Routine vaccination holds the largest market share by type in the travel vaccine market. It is helpful in developing immunity in humans against infectious diseases such as influenza, MMR, tuberculosis, diphtheria, etc. The other factors responsible for the dominance of routine vaccination are the rising prevalence of infectious diseases and proactive government policies to promote vaccination in all age groups.

Favorable reimbursement scenarios have a positive impact on the growth of the routine vaccination market. Recommended vaccinations are gaining popularity on account of facts such as the increasing number of visitors globally. They are taken two months in advance on a physician’s recommendation to build immunity against endemic diseases such as cholera, diarrhea, Japanese encephalitis, etc. Required vaccination will be the fastest-growing segment on account of factors such as the sudden outbreak of fatal diseases such as ebola, zika, malaria, and the Middle East respiratory syndrome.

Increasing public health awareness and well-developed healthcare infrastructure will drive market growth in North America.

North America is the clear leader in the travel vaccine market. The key factors driving the growth of the travel vaccines market in North America are rising public health awareness and the presence of a well-developed healthcare infrastructure. The presence of key players and the implementation of treatment guidelines emphasizing preventive care for citizens traveling abroad drive the North American market.

European medical agencies have made it mandatory for visitors to get vaccinated at the port of entry for infectious diseases such as tuberculosis, swine flu, and hepatitis B etc. Asia Pacific will showcase the fastest growth during the forecast period owing to the rising prevalence of infectious diseases and rampant growth in the tourism sector.

In order to prevent the spread of Middle East respiratory syndrome (MERS), the haj pilgrims in the Middle East and Africa are rigorously vaccinated. Since the outbreak of fatal diseases such as ebola and zika, healthcare agencies in Latin America and the African region have invested huge funds in developing vaccines to protect the health of their citizens.

Periods of History and Forecast

This research report presents the analysis of each segment from 2016 to 2026, considering 2017 as the base year for the research. The compound annual growth rate (CAGR) for each of the respective segments is calculated for the forecast period from 2018 to 2026.

Report Scope by Segments

The market estimation and compounded annual growth rate were calculated using organic and inorganic market growth analysis. The travel vaccines market is divided into two parts: type and geography.

The scope of the report includes a market assessment to understand the most recent market trends in the travel vaccines market. A comprehensive study was conducted to better understand the disease etiology of various infections encountered by travelers around the world, as well as the preventive measures taken by global healthcare organizations.

The competitive landscape is covered in the scope of the report to understand the competition existing among key players. The vaccines classified as routine recommended and required vaccinations are covered under the product portfolio segment. Major players providing travel vaccines are Baxter AG, Bharat Biotech, GlaxoSmithKline Plc., Inovio Pharmaceuticals, Inc., Merck & Co., Inc., Novartis AG, PaxVax Corporation, Sanofi Pasteur SA, Valneva SE, and VBI Vaccines, Inc.

Key questions are answered in this report.

• What are the market estimation and compound annual growth rates for the travel vaccine market?
• Who are the major players in the travel vaccine market?
• What are the treatment guidelines and vaccinations prescribed by regulatory bodies throughout the globe?
• What are the drivers, challenges, and opportunities existing in the travel vaccine market?
• What is the competitive scenario existing in the travel vaccine market?
• Which segment of the travel vaccines market is the most dominant and fastest growing?
• Which is the leading and fastest-growing regional segment for the travel vaccine market?

Chapter 1. Preface
1.1. Report Scope and Description
1.1.1. Purpose of the Report
1.1.2. Target Audience
1.1.3. USP and Key Offerings
1.2. Research Scope
1.3. Research Methodology
1.3.1. Phase I-Secondary Research
1.3.2. Phase II-Primary Research
1.3.3. Approach Adopted
1.3.4. Top-down Approach
1.3.5. Bottom-up Approach
1.3.6. Phase III-Expert Panel Review
1.3.7. Assumptions
1.4. Market Segmentation

Chapter 2. Executive Summary
2.1. Global TV MarketTV Market Portraiture
2.2. Global TV MarketTV Market, by Type, 2017 (US$ Mn)
2.3. Global TV MarketTV Market, by Geography, 2017 (US$ Mn)

Chapter 3. Travel Vaccine (TV) Market: Dynamics and Future Outlook
3.1. Market Overview
3.2. Drivers
3.3. Challenges
3.4. Opportunities
3.5. Attractive Investment Proposition, by Geography, 2017
3.6. Competitive Analysis: Global TV MarketTV Market, by Key Players, 2017

Chapter 4. Global Travel Vaccine (TV) Market, by Type
4.1. Overview
4.2. Routine Vaccination
4.2.1. Hepatitis B
4.2.2. Influenza
4.2.3. MMR
4.2.4. Tuberculosis
4.2.5. Others
4.3. Recommended Vaccination
4.3.1. Cholera
4.3.2. Japanese Encephalitis
4.3.3. Diarrhea
4.3.4. Yellow Fever
4.3.5. Others
4.4. Required Vaccination
4.4.1. Malaria
4.4.2. Ebola
4.4.3. Zika
4.4.4. Middle East Respiratory Syndrome
4.4.5. Others

Chapter 5. Global Travel Vaccine (TV) Market, by Geography
5.1. Overview
5.2. North America TV MarketTV Market Analysis, 2016 – 2026
5.2.1. North America TV MarketTV Market, by Type, 2016 – 2026 (US$ Mn)
5.2.2. North America TV MarketTV Market, by Country, 2016 – 2026 (US$ Mn)
5.2.2.1. U.S.
5.2.2.2. Canada
5.3. Europe TV MarketTV Market Analysis, 2016 – 2026
5.3.1. Europe TV MarketTV Market, by Type, 2016 – 2026 (US$ Mn)
5.3.2. Europe TV MarketTV Market, by Country/Region, 2016 – 2026 (US$ Mn)
5.3.2.1. U.K.
5.3.2.2. Germany
5.3.2.3. Rest of Europe
5.4. Asia Pacific TV MarketTV Market Analysis, 2016 – 2026
5.4.1. Asia Pacific TV MarketTV Market, by Type, 2016 – 2026 (US$ Mn)
5.4.2. Asia Pacific TV MarketTV Market, by Country/Region, 2016 – 2026 (US$ Mn)
5.4.2.1. China
5.4.2.2. Japan
5.4.2.3. Rest of Asia Pacific
5.5. Latin America TV MarketTV Market Analysis, 2016 – 2026
5.5.1. Latin America TV MarketTV Market, by Type, 2016 – 2026 (US$ Mn)
5.5.2. Latin America TV MarketTV Market, by Country/Region, 2016 – 2026 (US$ Mn)
5.5.2.1. Brazil
5.5.2.2. Mexico
5.5.2.3. Rest of Latin America
5.6. Middle East and Africa TV MarketTV Market Analysis, 2016 – 2026
5.6.1. MEA TV MarketTV Market, by Type, 2016 – 2026 (US$ Mn)
5.6.2. MEA TV MarketTV Market, by Country/Region, 2016 – 2026 (US$ Mn)
5.6.2.1. GCC
5.6.2.2. Rest of MEA

Chapter 6. Company Profiles
6.1. Baxter AG
6.1.1. Business Description
6.1.2. Financial Information (Subject to data availability)
6.1.3. Type Portfolio
6.1.4. News Coverage
6.2. Bharat Biotech
6.3. GlaxoSmithkline, Plc.
6.4. Inovio Pharmaceuticals, Inc.
6.5. Merck & Co., Inc.
6.6. Novartis AG
6.7. PaxVax Corporation
6.8. Sanofi Pasteur SA
6.9. Valneva SE
6.10. VBI Vaccines, Inc.

List of Figures

FIG. 1 Travel Vaccine (TV) Market: Research Methodology
FIG. 2 TV Market Segmentation
FIG. 3 Global TV Market, by Type, 2017 (US$ Mn)
FIG. 4 Global TV Market, by Geography, 2017 (US$ Mn)
FIG. 5 Attractive Investment Proposition: by Geography, 2017
FIG. 6 Competitive Analysis: Global TV Market, by Key Players, 2017
FIG. 7 Global Hepatitis B TV Market, 2016 – 2026 (US$ Mn)
FIG. 8 Global Influenza TV Market, 2016 – 2026 (US$ Mn)
FIG. 9 Global MMR TV Market, 2016 – 2026 (US$ Mn)
FIG. 10 Global Tuberculosis TV Market, 2016 – 2026 (US$ Mn)
FIG. 11 Global Other Routine TV Market, 2016 – 2026 (US$ Mn)
FIG. 12 Global Cholera TV Market, 2016 – 2026 (US$ Mn)
FIG. 13 Global Japanese Encephalitis TV Market, 2016 – 2026 (US$ Mn)
FIG. 14 Global Diarrhea TV Market, 2016 – 2026 (US$ Mn)
FIG. 15 Global Yellow Fever TV Market, 2016 – 2026 (US$ Mn)
FIG. 16 Global Other Recommended TV Market, 2016 – 2026 (US$ Mn)
FIG. 17 Global Malaria TV Market, 2016 – 2026 (US$ Mn)
FIG. 18 Global Ebola TV Market, 2016 – 2026 (US$ Mn)
FIG. 19 Global Zika TV Market, 2016 – 2026 (US$ Mn)
FIG. 20 Global Middle East Respiratory Syndrome TV Market, 2016 – 2026 (US$ Mn)
FIG. 21 Global Other Required TV Market, 2016 – 2026 (US$ Mn)
FIG. 22 U.S. TV Market, 2016 – 2026 (US$ Mn)
FIG. 23 Canada TV Market, 2016 – 2026 (US$ Mn)
FIG. 24 U.K. TV Market, 2016 – 2026 (US$ Mn)
FIG. 25 Germany TV Market, 2016 – 2026 (US$ Mn)
FIG. 26 Rest of Europe TV Market, 2016 – 2026 (US$ Mn)
FIG. 27 China TV Market, 2016 – 2026 (US$ Mn)
FIG. 28 Japan TV Market, 2016 – 2026 (US$ Mn)
FIG. 29 Rest of Asia Pacific TV Market, 2016 – 2026 (US$ Mn)
FIG. 30 Brazil TV Market, 2016 – 2026 (US$ Mn)
FIG. 31 Mexico TV Market, 2016 – 2026 (US$ Mn)
FIG. 32 Rest of Latin America TV Market, 2016 – 2026 (US$ Mn)
FIG. 33 GCC TV Market, 2016 – 2026 (US$ Mn)
FIG. 34 Rest of MEA TV Market, 2016 – 2026 (US$ Mn)

List of Tables

TABLE 1 Global Travel Vaccine (TV) Market Portraiture
TABLE 2 Global TV Market, by Type, 2016 – 2026 (US$ Mn)
TABLE 3 Global Routine TV Market, by Type, 2016 – 2026 (US$ Mn)
TABLE 4 Global Recommended TV Market, by Type, 2016 – 2026 (US$ Mn)
TABLE 5 Global Required TV Market, by Type, 2016 – 2026 (US$ Mn)
TABLE 6 Global TV Market, by Geography, 2016 – 2026 (US$ Mn)
TABLE 7 North America TV Market, by Type, 2016 – 2026 (US$ Mn)
TABLE 8 North America TV Market, by Country, 2016 – 2026 (US$ Mn)
TABLE 9 Europe TV Market, by Type, 2016 – 2026 (US$ Mn)
TABLE 10 Europe TV Market, by Country/Region, 2016 – 2026 (US$ Mn)
TABLE 11 Asia Pacific TV Market, by Type, 2016 – 2026 (US$ Mn)
TABLE 12 Asia Pacific TV Market, by Country/Region, 2016 – 2026 (US$ Mn)
TABLE 13 Latin America TV Market, by Type, 2016 – 2026 (US$ Mn)
TABLE 14 Latin America TV Market, by Country/Region, 2016 – 2026 (US$ Mn)
TABLE 15 Middle East and Africa TV Market, by Type, 2016 – 2026 (US$ Mn)
TABLE 16 Middle East and Africa TV Market, by Country/Region, 2016 – 2026 (US$ Mn)
TABLE 17 Baxter AG: Company Snapshot (Business Description; Financial Information; Type Portfolio; Key Developments)
TABLE 18 Bharat Biotech: Company Snapshot (Business Description; Financial Information; Type Portfolio; Key Developments)
TABLE 19 GlaxoSmithkline, Plc.: Company Snapshot (Business Description; Financial Information; Type Portfolio; Key Developments)
TABLE 20 Inovio Pharmaceuticals, Inc.: Company Snapshot (Business Description; Financial Information; Type Portfolio; Key Developments)
TABLE 21 Merck & Co., Inc.: Company Snapshot (Business Description; Financial Information; Type Portfolio; Key Developments)
TABLE 22 Novartis AG.: Company Snapshot (Business Description; Financial Information; Type Portfolio; Key Developments)
TABLE 23 PaxVax Corporation: Company Snapshot (Business Description; Financial Information; Type Portfolio; Key Developments)
TABLE 24 Sanofi Pasteur SA: Company Snapshot (Business Description; Financial Information; Type Portfolio; Key Developments)
TABLE 25 Valneva SE: Company Snapshot (Business Description; Financial Information; Type Portfolio; Key Developments)
TABLE 26 VBI Vaccines, Inc.: Company Snapshot (Business Description; Financial Information; Type Portfolio; Key Developments)